Moreover, the study observed that expression levels of ERK, IGF-1, and GLUT4 were correlated with CRC clinical characteristics, such as tumor size, distant metastasis, and advanced stages (III/IV) [111]. This evidence concerns the gene IGF1 and neoplasm.